Jun 23

Chemical Profile and Clinical Efficacy of Micro-Fragmented Adipose-derived MSC Therapy in the Treatment of Knee Osteoarthritis

Check out the new article by long-time TOBI faculty, Dr. Gerard Malanga, published in Biologic Orthopedic Journal. By the year 2040, it is estimated that 25% of adults in the US will be diagnosed with osteoarthritis by a physician.  Osteoarthritis, considered as a progessive joint disorder due to “wear and tear,” has been described by researchers to involve a complex dynamic of pro-inflammatory mediators leading to an increase of enzymes that degrade soft-tissue supporting the joint. This article looks at...

Oct 11

TOBI 2018 Symposium Abstracts Published in Biologic Orthopedic Journal

On June 8-9, 2018, field leaders in orthopedics and regenerative medicine from around the world gathered to present new research, data, and best practices. These world-class physicians and surgeons lectured and debated on regenerative medicine topics such as PRP, bone marrow concentrate (BMC), lipoaspirate, spine, biologics in orthopedic surgery, sports medicine, and regulatory issues.The abstracts from those lectures are now published in Biologic Orthopedic Journal. Abstracts feature speakers including Allan Mishra, Freddie Fu, J. Peter Rubin, Jason Dragoo, James HC...

Jul 16

Comparing PRP and prolotherapy in the treatment of SI joint dysfunction

[section_tc][column_tc span='12'][text_tc trigger_pt='0' duration='1000' delay='0']Low back pain (LBP) is a significant source of morbidity that affects a significant portion of the population. While initially a mainstay in therapy, surgical interventions have come under intense scrutiny as research has questioned their efficacy in addressing LBP. Nonspecific LBP (NSLBP) is particularly difficult to treat because multiple etiologies can contribute to ongoing pain. Mechanical dysfunction of the sacroiliac joint (SIJ) has been targeted as a common source of low back pain amenable to...